retatrutide clinical trial safety data New Phase 3 just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats VisualAbstract: Retatrutide reduces body weight

However, pharmacological and preclinical data are gathering (Table 2)

Mounjaro is a once-weekly injection

Consequently, cost-effectiveness analyses and real-world effectiveness studies that incorporate adherence and discontinuation are needed to contextualise cerebrovascular benefit under routine-care conditions

Wegovy puede contribuir a un mayor riesgo de tumores de clulas C de la tiroides, pancreatitis aguda, enfermedad de la vescula biliar, hipoglucemia, lesin renal aguda, efectos secundarios gastrointestinales graves y un mayor riesgo de empeoramiento de la retinopata diabtica en personas con diabetes tipo 2

This study considers the potential benefits of GLP-1 RA for AUD, among those with diabetes and/or obesity

The triple mechanism addresses both reduced appetite and increased metabolism simultaneously